GLENMARK PHARMACEUTICALS LIMITED

Company Type: Manufacturer

Company Introduction:

Glenmark Pharmaceuticals Limited is an India-based global pharmaceutical company dedicated to discovering, developing, manufacturing, and marketing a wide range of pharmaceutical products. Established in 1977, Glenmark has grown into a significant player in the global pharmaceutical industry, known for its strong focus on research and development, particularly in the areas of novel chemical entities (NCEs) and novel biological entities (NBEs).

The company primarily operates as a manufacturer, possessing a network of advanced manufacturing facilities located in various countries. These facilities are compliant with international regulatory standards, enabling Glenmark to produce high-quality branded generics, generics, and Active Pharmaceutical Ingredients (APIs). Key therapeutic areas of focus for Glenmark include dermatology, respiratory, and oncology.

Glenmark Pharmaceuticals has a substantial global footprint, with products being marketed in numerous countries across North America, Europe, Latin America, and emerging markets. Its integrated operations cover the entire pharmaceutical value chain, from drug discovery and clinical development to commercialization. This comprehensive approach firmly establishes Glenmark as a pharmaceutical manufacturer with extensive production capabilities, rather than solely a trading company. The company is committed to innovation and providing accessible, high-quality healthcare solutions worldwide.

Glenmark Pharmaceuticals Limited Products:

* **Branded Generics:** Dermatologicals, respiratory products, cardiovascular drugs, anti-diabetic medications, and treatments for pain management.

* **Generics:** A wide range of generic pharmaceutical products.

* **API (Active Pharmaceutical Ingredients):** Manufacturing and supply of APIs for various therapeutic categories.

* **Novel Molecules:** Research and development of new chemical entities (NCEs) and biologics.